Tubulovesicular structures within vesicular stomatitis virus G protein-pseudotyped lentiviral vector preparations carry DNA and stimulate antiviral responses via Toll-like receptor 9.
about
Progress and prospects: immune responses to viral vectorsHighly efficient concentration of lenti- and retroviral vector preparations by membrane adsorbers and ultrafiltration.Simplified production and concentration of HIV-1-based lentiviral vectors using HYPERFlask vessels and anion exchange membrane chromatography.HIV-1 lentiviral vector immunogenicity is mediated by Toll-like receptor 3 (TLR3) and TLR7.Enhanced pseudotyping efficiency of HIV-1 lentiviral vectors by a rabies/vesicular stomatitis virus chimeric envelope glycoprotein.Characterization of retroviral and lentiviral vectors pseudotyped with xenotropic murine leukemia virus-related virus envelope glycoprotein.A nonintegrative lentiviral vector-based vaccine provides long-term sterile protection against malariaConventional dendritic cells are required for the activation of helper-dependent CD8 T cell responses to a model antigen after cutaneous vaccination with lentiviral vectors.Impact of Ebola mucin-like domain on antiglycoprotein antibody responses induced by Ebola virus-like particles.Development of the Nanobody display technology to target lentiviral vectors to antigen-presenting cells.Learning from the messengers: innate sensing of viruses and cytokine regulation of immunity - clues for treatments and vaccines.Mutations in human immunodeficiency virus type 1 nucleocapsid protein zinc fingers cause premature reverse transcriptionDendritic cells for active anti-cancer immunotherapy: targeting activation pathways through genetic modification.Emerging applications of lentiviral vectors in dendritic cell-based immunotherapy.Targeting lentiviral vectors for cancer immunotherapy.Lentiviral vectors for cancer immunotherapy and clinical applicationsDendritic Cells Cross-Present Immunogenic Lentivector-Encoded Antigen from Transduced Cells to Prime Functional T Cell Immunity.Combination of lentivector immunization and low-dose chemotherapy or PD-1/PD-L1 blocking primes self-reactive T cells and induces anti-tumor immunity.A lentiviral vector pseudotype suitable for vaccine development.The degenerating substantia nigra as a susceptible region for gene transfer-mediated inflammation.Dendritic cell-targeted lentiviral vector immunization uses pseudotransduction and DNA-mediated STING and cGAS activation.Sensing of HIV-1 Entry Triggers a Type I Interferon Response in Human Primary Macrophages.Viruses transfer the antiviral second messenger cGAMP between cells.Transmission of innate immune signaling by packaging of cGAMP in viral particles.Construction of stable packaging cell lines for clinical lentiviral vector production.Immunization with a lentivector that targets tumor antigen expression to dendritic cells induces potent CD8+ and CD4+ T-cell responses.A TLR and non-TLR mediated innate response to lentiviruses restricts hepatocyte entry and can be ameliorated by pharmacological blockade.Lentiviral vector-based prime/boost vaccination against AIDS: pilot study shows protection against Simian immunodeficiency virus SIVmac251 challenge in macaques.Advances in Overcoming Immune Responses following Hemophilia Gene Therapy.Lentivectors are efficient tools to manipulate the dendritic cell cytoskeleton.Cell and Gene Therapy for HIV Cure.Mass spectrometry analysis reveals differences in the host cell protein species found in pseudotyped lentiviral vectors.Lentiviral-mediated gene transfer – a patent reviewLentivector Producer Cell Lines with Stably Expressed Vesiculovirus Envelopes
P2860
Q28264531-D11D8DD3-04DD-4895-9CC4-0A9BA260A466Q31014077-09CBDC8D-0B6A-44ED-B65E-CAD26C1B3AA0Q33409769-34281A6B-39D6-4FDF-8B0E-F117E7202C2AQ33877397-22B2304A-77FF-41AE-AAB3-862CCBFCBBE2Q34214473-B2D36488-AC54-46C9-A5D8-B1A9A15E9F09Q34393161-ED52BBC3-6110-478A-84E5-CBA9D24D21A6Q34469817-69ADC90B-A719-4E6E-A5C8-C8A715F8F3F6Q34767725-C9849374-E458-4C1E-9332-D4B8AE5AAC58Q35299756-4A572FBB-C2C9-4621-A134-34FC7465BAD8Q36460535-ED80B554-A70C-4B8D-B6EF-C3901A53BE49Q36807121-101CAA3C-DBBC-4B11-93A5-19675D84797BQ36898781-0C78A45A-3AA2-4269-B805-758ECDABDA35Q37621566-E6E82D53-A005-48E3-8D2F-AA07B92E71F8Q37793233-E1B79159-0950-41F0-9B3F-7123323C6A2FQ38043924-7075EA9D-27FD-410A-9E48-8052647144E2Q38147100-3467A10C-8073-4642-8FE4-229CF7A5E52BQ38762699-333B5ED0-A384-4B7A-8B76-5CCE8F4552CFQ39549328-61AB9BB1-5AA9-48E8-AAFC-C084F80BD9F6Q39577673-6E26E68F-3BA8-4229-BC8D-A4B8278345E8Q39737653-06E711DA-EBCE-4C44-A101-F10BDD63BB4DQ40112787-A2E71C15-8194-42DA-8180-908ABBD07674Q40207016-42DBF59B-498B-4CAB-8069-AACA26CA230FQ41079643-65742539-9FB7-4062-BC57-71C03C3023C4Q41079648-8306519A-FBFC-4728-8660-EF18C47B6C88Q41437137-47DC4430-6221-441B-AD50-FEF550E058ECQ41913779-4B19392B-B3C8-4451-BABF-AB9B3C096AA1Q42119020-CB9BE468-65CF-46EC-921B-9B223E4AB282Q42131361-88DBD2E2-05EC-4F3A-BBE5-0D0A06EA8C22Q42209182-69A8FD37-F615-4A2D-8171-ABA5D9E5451CQ45871804-31622795-6B81-409C-A741-8E9BDEB0DFE8Q47236016-CB95E373-E6B3-44B2-A67B-355B868B649AQ47549751-B7C514D1-7679-4A0F-96D9-C871E881B450Q56787021-9A55CC21-8A47-44C6-AF61-08312E670C81Q58796850-EAF1C343-2A7C-4D65-A665-6DEE1C5F1F3C
P2860
Tubulovesicular structures within vesicular stomatitis virus G protein-pseudotyped lentiviral vector preparations carry DNA and stimulate antiviral responses via Toll-like receptor 9.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Tubulovesicular structures wit ...... nses via Toll-like receptor 9.
@en
type
label
Tubulovesicular structures wit ...... nses via Toll-like receptor 9.
@en
prefLabel
Tubulovesicular structures wit ...... nses via Toll-like receptor 9.
@en
P2093
P2860
P356
P1433
P1476
Tubulovesicular structures wit ...... nses via Toll-like receptor 9.
@en
P2093
Andreas Pichlmair
Mary K Collins
Sandra S Diebold
Stephen Gschmeissner
Yasuhiro Ikeda
Yasuhiro Takeuchi
P2860
P304
P356
10.1128/JVI.01818-06
P407
P577
2006-11-01T00:00:00Z